Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder.

Simon NM, Safren SA, Otto MW, Sharma SG, Lanka GD, Pollack MH.

J Affect Disord. 2002 May;69(1-3):201-8.

PMID:
12103467
2.
4.

A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.

Toni C, Perugi G, Frare F, Mata B, Vitale B, Mengali F, Recchia M, Serra G, Akiskal HS.

Pharmacopsychiatry. 2000 Jul;33(4):121-31.

PMID:
10958260
6.

The longitudinal course and outcome of panic disorder.

Pollack MH, Smoller JW.

Psychiatr Clin North Am. 1995 Dec;18(4):785-801. Review.

PMID:
8748381
7.

Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.

Maina G, Rosso G, Bogetto F.

J Affect Disord. 2009 Apr;114(1-3):200-7. doi: 10.1016/j.jad.2008.07.010. Epub 2008 Aug 26.

8.

Three-year medication prophylaxis in panic disorder: to continue or discontinue? A naturalistic study.

Choy Y, Peselow ED, Case BG, Pressman MA, Luff JA, Laje G, Paizis M, Ying P, Guardino MT.

Compr Psychiatry. 2007 Sep-Oct;48(5):419-25. Epub 2007 Jul 5.

PMID:
17707249
9.

A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.

Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):326-34.

PMID:
18090457
10.

An open-label trial of risperidone augmentation for refractory anxiety disorders.

Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH.

J Clin Psychiatry. 2006 Mar;67(3):381-5.

PMID:
16649823
11.

Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines.

Rapaport MH, Pollack MH, Clary CM, Mardekian J, Wolkow R.

J Clin Psychopharmacol. 2001 Feb;21(1):104-7.

PMID:
11199932
12.

Diagnosis and management of panic disorder in older patients.

Flint AJ, Gagnon N.

Drugs Aging. 2003;20(12):881-91. Review.

PMID:
14565781
13.

Panic disorder: long-term pharmacotherapy and discontinuation.

Rickels K, Schweizer E.

J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):12S-18S. Review.

PMID:
9872708
14.

Long-term outcome of patients with dysthymia and panic disorder: a naturalistic 9-year follow-up study.

Svanborg C, Wistedt AA, Svanborg P.

Nord J Psychiatry. 2008;62(1):17-24. doi: 10.1080/08039480801960123.

PMID:
18389421
15.

Clinical issues in the long-term treatment of panic disorder.

Rosenbaum JF, Pollack MH, Pollock RA.

J Clin Psychiatry. 1996;57 Suppl 10:44-8; discussion 49-50. Review.

PMID:
8917131
16.

Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

Dannon PN, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M.

BMC Psychiatry. 2004 Jun 11;4:16.

17.
18.

One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission.

Heldt E, Gus Manfro G, Kipper L, Blaya C, Isolan L, Otto MW.

Behav Res Ther. 2006 May;44(5):657-65. Epub 2005 Jul 20.

PMID:
16038874
19.

Medication discontinuation in panic disorder.

Ballenger JC.

J Clin Psychiatry. 1992 Mar;53 Suppl:26-31. Review.

PMID:
1548252
20.

Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.

Bakker A, van Balkom AJ, Spinhoven P, Blaauw BM, van Dyck R.

J Nerv Ment Dis. 1998 Jul;186(7):414-9.

PMID:
9680042

Supplemental Content

Support Center